Aytu BioPharma approves $118K CEO bonus and $83K CFO bonus for 2023

AYTU BIOPHARMA, INC

CEO Joshua R. Disbrow awarded $118,000 bonus (33% of target).
CFO Mark K. Oki awarded $83,000 bonus (50% of target).
Bonuses to be paid in January 2024; full payment if employment terminates early.
Approved by Compensation Committee on August 11, 2023.

item 5.02

AYTU BIOPHARMA, INC filing history →

Source: SEC EDGAR

accession 0001558370-23-014996

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.